177 related articles for article (PubMed ID: 38252353)
1. The non-vesicle cell-free DNA (cfDNA) induces cell transformation associated with horizontal DNA transfer.
De La Cruz-Sigüenza DA; Reyes-Grajeda JP; Velasco-Velázquez MA; Trejo-Becerril C; Pérez-Cárdenas E; Chávez-Blanco A; Taja-Chayeb L; Domínguez-Gómez G; Ramos-Godinez MP; González-Fierro A; Dueñas-González A
Mol Biol Rep; 2024 Jan; 51(1):174. PubMed ID: 38252353
[TBL] [Abstract][Full Text] [Related]
2. Cancer progression mediated by horizontal gene transfer in an in vivo model.
Trejo-Becerril C; Pérez-Cárdenas E; Taja-Chayeb L; Anker P; Herrera-Goepfert R; Medina-Velázquez LA; Hidalgo-Miranda A; Pérez-Montiel D; Chávez-Blanco A; Cruz-Velázquez J; Díaz-Chávez J; Gaxiola M; Dueñas-González A
PLoS One; 2012; 7(12):e52754. PubMed ID: 23285175
[TBL] [Abstract][Full Text] [Related]
3. Extracellular Vesicle-Derived DNA vs. CfDNA as a Biomarker for the Detection of Colon Cancer.
Thakur K; Singh MS; Feldstein-Davydova S; Hannes V; Hershkovitz D; Tsuriel S
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440345
[TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA.
Lee JS; Hur JY; Kim IA; Kim HJ; Choi CM; Lee JC; Kim WS; Lee KY
BMC Cancer; 2018 Dec; 18(1):1236. PubMed ID: 30526536
[TBL] [Abstract][Full Text] [Related]
5. Digital PCR-based evaluation of nucleic acid extraction kit performance for the co-purification of cell-free DNA and RNA.
Deleu J; Schoofs K; Decock A; Verniers K; Roelandt S; Denolf A; Verreth J; De Wilde B; Van Maerken T; De Preter K; Vandesompele J
Hum Genomics; 2022 Dec; 16(1):73. PubMed ID: 36587211
[TBL] [Abstract][Full Text] [Related]
6. Cell-free DNA topology depends on its subcellular and cellular origins in cancer.
Malkin EZ; De Michino S; Lambie M; Gill R; Zhao Z; Rostami A; Arruda A; Minden MD; Bratman SV
JCI Insight; 2022 Oct; 7(20):. PubMed ID: 36125881
[TBL] [Abstract][Full Text] [Related]
7. Release of bulk cell free DNA during physical exercise occurs independent of extracellular vesicles.
Helmig S; Frühbeis C; Krämer-Albers EM; Simon P; Tug S
Eur J Appl Physiol; 2015 Nov; 115(11):2271-80. PubMed ID: 26126838
[TBL] [Abstract][Full Text] [Related]
8. Concentration of cell-free DNA in different tumor types.
Bryzgunova OE; Konoshenko MY; Laktionov PP
Expert Rev Mol Diagn; 2021 Jan; 21(1):63-75. PubMed ID: 33270495
[No Abstract] [Full Text] [Related]
9. Cross-platform comparison of next-generation sequencing and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for detecting KRAS/NRAS/BRAF/PIK3CA mutations in cfDNA from metastatic colorectal cancer patients.
Xu X; Huang F; Cao M; Chen X; Wang H; Jiang H; Yu Y; Shen M; Yang Y; Wang B; Liu T; Guo W
J Clin Lab Anal; 2021 Sep; 35(9):e23818. PubMed ID: 34403504
[TBL] [Abstract][Full Text] [Related]
10. An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues.
Ono Y; Sugitani A; Karasaki H; Ogata M; Nozaki R; Sasajima J; Yokochi T; Asahara S; Koizumi K; Ando K; Hironaka K; Daito T; Mizukami Y
Mol Oncol; 2017 Oct; 11(10):1448-1458. PubMed ID: 28691390
[TBL] [Abstract][Full Text] [Related]
11. The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer.
Berchuck JE; Facchinetti F; DiToro DF; Baiev I; Majeed U; Reyes S; Chen C; Zhang K; Sharman R; Uson Junior PLS; Maurer J; Shroff RT; Pritchard CC; Wu MJ; Catenacci DVT; Javle M; Friboulet L; Hollebecque A; Bardeesy N; Zhu AX; Lennerz JK; Tan B; Borad M; Parikh AR; Kiedrowski LA; Kelley RK; Mody K; Juric D; Goyal L
Ann Oncol; 2022 Dec; 33(12):1269-1283. PubMed ID: 36089135
[TBL] [Abstract][Full Text] [Related]
12. A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR-Mutant Non-Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial.
Yanagita M; Redig AJ; Paweletz CP; Dahlberg SE; O'Connell A; Feeney N; Taibi M; Boucher D; Oxnard GR; Johnson BE; Costa DB; Jackman DM; Jänne PA
Clin Cancer Res; 2016 Dec; 22(24):6010-6020. PubMed ID: 27281561
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele Frequency.
Bustamante Alvarez JG; Janse S; Owen DH; Kiourtsis S; Bertino EM; He K; Carbone DP; Otterson GA
Clin Lung Cancer; 2021 Jul; 22(4):e519-e527. PubMed ID: 33414052
[TBL] [Abstract][Full Text] [Related]
14. Serial profiling of cell-free DNA and nucleosome histone modifications in cell cultures.
Ungerer V; Bronkhorst AJ; Van den Ackerveken P; Herzog M; Holdenrieder S
Sci Rep; 2021 May; 11(1):9460. PubMed ID: 33947882
[TBL] [Abstract][Full Text] [Related]
15. High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer.
Ashley CW; Selenica P; Patel J; Wu M; Nincevic J; Lakhman Y; Zhou Q; Shah RH; Berger MF; Da Cruz Paula A; Brown DN; Marra A; Iasonos A; Momeni-Boroujeni A; Alektiar KM; Long Roche K; Zivanovic O; Mueller JJ; Zamarin D; Broach VA; Sonoda Y; Leitao MM; Friedman CF; Jewell E; Reis-Filho JS; Ellenson LH; Aghajanian C; Abu-Rustum NR; Cadoo K; Weigelt B
Clin Cancer Res; 2023 Jan; 29(2):410-421. PubMed ID: 36007103
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal Multi-Parametric Liquid Biopsy Approach Identifies Unique Features of Circulating Tumor Cell, Extracellular Vesicle, and Cell-Free DNA Characterization for Disease Monitoring in Metastatic Breast Cancer Patients.
Keup C; Suryaprakash V; Storbeck M; Hoffmann O; Kimmig R; Kasimir-Bauer S
Cells; 2021 Jan; 10(2):. PubMed ID: 33494385
[TBL] [Abstract][Full Text] [Related]
17. Detection of HTLV-1 proviral DNA in cell-free DNA: Potential for non-invasive monitoring of Adult T cell leukaemia/lymphoma using liquid biopsy?
Joris T; Haddow J; Taylor GP; Cook LBM; Rowan AG
Front Immunol; 2023; 14():1150285. PubMed ID: 37114063
[TBL] [Abstract][Full Text] [Related]
18. Clonal diversity in KRAS mutant colorectal adenocarcinoma under treatment: Monitoring of cfDNA using reverse hybridization and DNA sequencing platforms.
Bádon ES; Mokánszki A; Mónus A; András C; Méhes G
Mol Cell Probes; 2023 Feb; 67():101891. PubMed ID: 36586518
[TBL] [Abstract][Full Text] [Related]
19. Distinct profile of cell-free DNA in malignant pleural effusion of non-small cell lung cancer and its impact on clinical genetic testing.
Yu Y; Qian J; Shen L; Ji W; Lu S
Int J Med Sci; 2021; 18(6):1510-1518. PubMed ID: 33628109
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer.
Lapin M; Tjensvoll K; Nedrebø K; Taksdal E; Janssen H; Gilje B; Nordgård O
PLoS One; 2023; 18(9):e0291623. PubMed ID: 37708210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
